CN106344262A - Eye patch for relieving visual fatigue - Google Patents
Eye patch for relieving visual fatigue Download PDFInfo
- Publication number
- CN106344262A CN106344262A CN201611054594.XA CN201611054594A CN106344262A CN 106344262 A CN106344262 A CN 106344262A CN 201611054594 A CN201611054594 A CN 201611054594A CN 106344262 A CN106344262 A CN 106344262A
- Authority
- CN
- China
- Prior art keywords
- parts
- eyeshield
- asthenopic
- cover body
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003464 asthenopia Diseases 0.000 title abstract description 23
- 239000011324 bead Substances 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 16
- 238000010438 heat treatment Methods 0.000 claims abstract description 12
- 238000001467 acupuncture Methods 0.000 claims abstract description 5
- 230000000079 pharmacotherapeutic effect Effects 0.000 claims description 24
- 206010037660 Pyrexia Diseases 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 20
- 239000011229 interlayer Substances 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 16
- 239000003513 alkali Substances 0.000 claims description 15
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 15
- 239000009969 fructus bruceae Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 7
- 239000004917 carbon fiber Substances 0.000 claims description 7
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000005030 aluminium foil Substances 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 25
- 238000013461 design Methods 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 3
- 239000012528 membrane Substances 0.000 abstract description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 4
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 239000000377 silicon dioxide Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 10
- 230000004310 photopic vision Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 238000000015 thermotherapy Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 208000027993 eye symptom Diseases 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 208000029091 Refraction disease Diseases 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000004430 ametropia Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 208000014733 refractive error Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 235000010894 Artemisia argyi Nutrition 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 206010002537 anisometropia Diseases 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 201000009310 astigmatism Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 206010053398 Clonic convulsion Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- -1 Herba Menthae Substances 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 235000009694 Quassia amara Nutrition 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044074 Torticollis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000018197 inherited torticollis Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000005439 thermosphere Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/04—Eye-masks ; Devices to be worn on the face, not intended for looking through; Eye-pads for sunbathing
- A61F9/045—Eye-shades or visors; Shields beside, between or below the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H15/00—Massage by means of rollers, balls, e.g. inflatable, chains, or roller chains
- A61H15/0078—Massage by means of rollers, balls, e.g. inflatable, chains, or roller chains power-driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H15/00—Massage by means of rollers, balls, e.g. inflatable, chains, or roller chains
- A61H15/02—Massage by means of rollers, balls, e.g. inflatable, chains, or roller chains adapted for simultaneous treatment with light, heat or drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/04—Devices for pressing such points, e.g. Shiatsu or Acupressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0002—Head or parts thereof
- A61F2007/0004—Eyes or part of the face surrounding the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/01—Constructive details
- A61H2201/0157—Constructive details portable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0207—Characteristics of apparatus not provided for in the preceding codes heated or cooled heated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
- A61H2201/105—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy with means for delivering media, e.g. drugs or cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/16—Physical interface with patient
- A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
- A61H2201/165—Wearable interfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/02—Head
- A61H2205/022—Face
- A61H2205/024—Eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Rehabilitation Therapy (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides an eye patch for relieving visual fatigue and belongs to the technical field of eye patches. The eye patch comprises a cover and Velcro fixing bands, multiple sandwiched layers I are arranged inside a cavity of the cover, heating pieces and medicine therapy bags are sequentially arranged in the direction of eyes of a human body inside the sandwiched layers I, a movable cover is arranged at the position, corresponding to the cavity, of the cover, a silica membrane is arranged on the face, making contact with the eyes, of the cover, protruding bubbles are arranged at the positions, corresponding to acupuncture points around the eyes, of the silica membrane, massage beads are arranged inside all the protruding bubbles and connected with a vibration motor which is connected with a power source, a temperature sensor and a microcontroller are arranged inside the cover, and the temperature sensor is sequentially connected with the microcontroller and the power source through wires. The compliableness and comfort level of the eye patch are improved, the effect of relieving visual fatigue is enhanced from the perspective of a short term and a long term, the good effects of relieving and treating visual fatigue are achieved through the combination of thermal therapy, medicine therapy and massage, safety is higher, structural design is reasonable, and using is convenient.
Description
Technical field
The invention belongs to eyeshield technical field is and in particular to a kind of alleviate asthenopic eyeshield.
Background technology
Currently, adolescent students learning tasks are more and more heavier, and learning time extends, the ametropic sickness rate of eye
It is being continuously increased.There occurs ametropia, a lot of students contemplate and correct defects of vision.Improper yet with the eyeglass number of degrees, excessively strong,
Correct not in place and anisometropia occurs, all can produce asthenopia phenomenon.Glasses are axially displaced from and can produce new astigmatism.In order to gram
Take the generation of vision interference phenomenon, obtain binocular single vision, the strength employing eye muscle is adjusted by human body, and time one length will be sent out
Myogenic asthenopia.
It is in junior middle school, the student of senior high school period study, learning time is longer, makes eyes be in fatigue state for a long time.Have
Position scientist has ever done a test, invites 24 aspiration university students as experimenter, is regarded with the distance of 20cm, 40cm respectively
Thing 20 minutes, it is found that be easier asthenopia depending on nearly thing.This research supports opposes long-time close eye
Theory, also demonstrates the relation of asthenopia and view distance simultaneously.Examine in facing, the student of college entrance examination often little in school study 8 ~ 9
Shi Yihou, go home also to bend over the desk study for a long time in the evening.This study often closely, persistence, for eyes
Health care is very unfavorable.And abnormal sitting posture, torticollis write, by bus reading, read when lighting not good, also can induce and increase to regard
The generation of fatigue.
Modern medicine is thought, asthenopia is one group and shows as with visual disorder, ophthalmic uncomfortable and General Symptomies after eye,
The syndrome group regarding thing can not be normally carried out, therefore, be clinically again frequently referred to " eyestrain's syndrome ", be eye or systemic factor with
The syndrome that spiritual (psychological) factor is interweaved, belongs to psychosomatic medicine category.Patient is usually expressed as the swollen sense of acid of eye, burning
Burn sense, foreign body sensation, shed tears, the symptom such as photophobia, blurred vision, diplopia, eyes are dry and astringent, severe patient even occur headache, nauseous, vomit
The General Symptomies such as tell.Modern is due to the quickening of work rhythm, the increase of life stress, the flourishing and various handss of communication network
Mechanical, electrical regard, the extensive utilization of the various video terminals such as computer, its clinical onset rate sharply increases, according to statistics, asthenopia in recent years
Sickness rate up to 46.3%, the serious physical and mental health threatening the mankind.The asthenopia cause of disease is complicated, main and eye factor and the external world
Factor is related.Eye factor includes ametropia, irregular;Ocular accommodation obstacle, function of ocular muscle abnormal (inside and outside hidden tiltedly etc.),
Eye organic disease includes ocular and retinopathy, and the ocular surface function that a variety of causes leads to is abnormal, tear film is unstable etc.;Extraneous
Factor includes occurring under the common participation of the factors such as environment, physical factor, position and spirit nerve.At present, asthenopic
Treatment is mainly based on eye local application and operation.But eye local long-term prescription, asthenopic simultaneously in alleviation, to ocular
There is certain infringement, and big drug contains preservative, life-time service can cause to eye to damage;Operation mostly is invasive and controls
Treat, and do not take into full account systemic conditions.
Based on problem above, people have developed the health promoting products of many correlations, with when eyes feel fatigue so that it may
To carry out loosening of local, thus alleviating and eliminating asthenopia, for example, patent cn201310442529.4 discloses a kind of many work(
Can eyeshield, outside is made up of on and off switch, intensity selection key, bottom, protecgulum, massage head, internal by mainboard, power supply, heater strip,
Vibrating motor, bluetooth module composition.Under mainboard control, vibration motor produces shock effect, and eye peripheral point is massaged;Electricity
Frequency stimulates and can promote veins beneath the skin expansion, activates eye wholeheartedly meridians;By arranging heater strip in point ex-hn 4, to point ex-hn 4 hot compress,
Accelerate eye toxin expelling drainability.But poor using rear eye comfortableness, acceptance is relatively low.Patent cn201520235997.9
Disclose a kind of near-sighted fatigue eyeglasses of alleviation, nose support is installed inside picture frame, picture frame surface is installed and is equipped with chute, massage frame is installed
On chute, picture frame two ends are provided with temple, and picture frame is provided with display lamp with the junction of temple, temple is provided with massage
Pad, is provided with mini vibrator and power module, power module is connected with display lamp and mini vibrator respectively inside massage cushion
Connect.This glasses is massaged to eye by mini vibrator, and heating cushion heats to eye, for fatigue alleviating;Instruction
Lamp lights suggesting effect.But the program improves to lens body, increased the weight of glasses and eye wears burden, plus
Weigh the compressing to ear for the glasses.Therefore, although technique scheme all have alleviate eye strain effect, exist according to
Poor from degree, acceptance, or defect is substantially, should not wear, or only pay attention to external massage or stimulation, and physiotheraping effect is poor etc.
Problem.
Content of the invention
In view of this, the technical problem to be solved is to provide a kind of compliance more preferably, and physiotheraping effect is obvious,
The higher alleviation asthenopia eyeshield of safety.
For solving above-mentioned technical problem, the technical solution adopted in the present invention is:
A kind of asthenopic eyeshield of alleviation, including cover body, the two ends setting magic of described cover body glues fixing band, and described cover body corresponds to
Human body eye locations outwardly form cavity, arrange and point to human body eye in some interlayers, described interlayer in described cavity
Direction sets gradually fever tablet and pharmaco-therapeutic bag, upper side setting removable cover, described cover body and the eye of the corresponding cavity of described cover body
The one side setting pellosil of contact, the corresponding circumference of eyes acupuncture point of described pellosil is provided with prominent vesicle, each described prominent vesicle
Interior setting massage bead, described massage bead connecting vibration motor, described vibrating motor and power supply connect, setting temperature in described cover body
Sensor and microcontroller, described temperature sensor is connected with microcontroller and power supply successively by wire.
Preferably, described massage bead is fixed in connecting rod, and described connecting rod is connected with described vibrating motor.
Preferably, described connecting rod is fixed on the inside of described cover body by elastic component.
Preferably, described cover body inner surface lays aluminium foil reflectance coating.
Preferably, described interlayer is carbon fiber interlayer.
Preferably, described fever tablet is Electric radiant Heating Film or Far infrared carbon fiber fever tablet, and described fever tablet is connected with power supply.
Preferably, setting Folium Artemisiae Argyi in described pharmaco-therapeutic bag.
Preferably, described pharmaco-therapeutic bag is the bag of installing treatment solution, and described treatment solution is prepared by the raw material of following weight portion
Form: 5 ~ 10 parts of salt alkali, 10 ~ 20 parts of Herba Menthae, 10 ~ 20 parts of Fructus Aurantii Immaturus, 5 ~ 10 parts of Radix Bupleuri, 5 ~ 10 parts of Rhizoma Dioscoreae, 3 ~ 8 parts of Folium et cacumen Breyniae Fruticosae, crow
3 ~ 8 parts of courage, 1 ~ 5 part of Melanteritum.
Preferably, described pharmaco-therapeutic bag is the bag of installing treatment solution, and described treatment solution is prepared by the raw material of following weight portion
Form: 8 parts of salt alkali, 15 parts of Herba Menthae, 15 parts of Fructus Aurantii Immaturus, 8 parts of Radix Bupleuri, 7 parts of Rhizoma Dioscoreae, 5 parts of Folium et cacumen Breyniae Fruticosae, 6 parts of Fructus Bruceae, 3 parts of Melanteritum.
Preferably, described treatment solution is prepared by method acquisition, specifically includes:
Weigh Herba Menthae, Fructus Aurantii Immaturus, Radix Bupleuri, Rhizoma Dioscoreae, Folium et cacumen Breyniae Fruticosae and the Fructus Bruceae of above-mentioned weight portion, be added to supercritical co2 extraction kettle
In, extracted for entrainer using volume fraction 95% ethanol, set extracting pressure 10 ~ 20mpa, 30 ~ 40 DEG C of temperature, co2 flows
Body flow 40 ~ 50l/h, extracts 1.5 ~ 3h, and gained extract frozen centrifugation removes impurity, obtains pure extract;
2) weigh salt alkali and the Melanteritum of above-mentioned weight portion, be ground to powder, add to described pure extract, stirring mixing,
Standing obtains final product.
Compared with prior art, beneficial effects of the present invention are as follows:
Eyeshield of the present invention is used for alleviating the visual fatigue of human body, improves the blood circulation of eye and surrounding, promotes the eye stasis of blood stagnant
Dissolve.For improving compliance, adopt pellosil with the one side of human contact, docile degree is high, heat conductivity is good, comfortable feel;For adding
Strong remission effect, realizes inner disease outer treat, and this eyeshield is provided with fever tablet and pharmaco-therapeutic bag in the cavity of corresponding human body eye, and
Fever tablet and pharmaco-therapeutic bag can be taken out by removable cover and change, and the setting of fever tablet is partly in order to realization office
On the other hand portion's thermotherapy, also plays the effect of heating to the medicine of pharmaco-therapeutic bag, and then promotes the performance of drug effect and eye meridians
Dredging and the circulation of blood;In combination with the use of pellosil, massage bead is dexterously arranged on inside pellosil by this eyeshield, profit
With reserved prominent imitated vesicle structure, massage bead is wrapped in it, then massage bead is connected with vibrating motor, realize local
Acupoint massage, such massage bead not with direct body contact, material selectivity is wider, is carried out without to massage bead,
Become simpler using process;In order to safety and automatically control the temperature of cover inframe side, the present invention sets in cover body
There are temperature sensor and microcontroller, when temperature exceedes design temperature, microcontroller cuts off the electrical connection of heating layer, stops
Only heat;This eyeshield can conveniently control the work of vibrating motor, fever tablet and temperature sensor in the presence of microcontroller
Industry, thus realize comfortable, safely and effectively alleviate asthenopic purpose.
Eyeshield of the present invention, is increased so that the compliance using and comfortableness improve by organic cooperation of above-mentioned technical characteristic
Alleviate by force asthenopic short-term and long-term effect, combined by thermotherapy, medication and massage, reach good alleviation and treatment regards
The effect of fatigue, and safety is higher, reasonable in design, easy to use.
Brief description
The present invention is described in further detail below in conjunction with the accompanying drawings:
Fig. 1: the present invention alleviates the schematic perspective view of asthenopia eyeshield;
Fig. 2: the present invention alleviates the structural representation of asthenopia eyeshield;
Fig. 3: Fig. 2 of the present invention a-a sectional view;
Fig. 4: the present invention alleviates the side view of asthenopia eyeshield;
Wherein, 1- cover body, 2- magic glues fixing band, 3- cavity, 4- interlayer, 5- fever tablet, 6- pharmaco-therapeutic bag, 7- removable cover, 8- silicon
Glued membrane, 9- projects vesicle, 10- massage bead, 11- vibrating motor, 12- power supply, 13- temperature sensor, 14- microcontroller, 15-
Wire, 16- connecting rod, 17- elastic component, 18- aluminium foil reflectance coating, 19- haftplatte, 20- groove, 21- interlayer.
Specific embodiment
For a better understanding of the present invention, fairly set out present disclosure further with reference to embodiment, but this
Bright protection content is not limited solely to the following examples.In the following description, give a large amount of concrete details so that
More thorough understanding of the invention is provided.It will be apparent, however, to one skilled in the art that the present invention is permissible
Need not one or more of these details and be carried out.
Embodiment 1
Refering to Fig. 1 ~ 4, the invention provides a kind of alleviate asthenopic eyeshield, including cover body 1, the two ends setting evil spirit of described cover body
Art glues fixing band 2, and the corresponding human body eye locations of described cover body outwardly form cavity 3, arrange some interlayers in described cavity
4, point to human body eye direction in described interlayer and set gradually fever tablet 5 and pharmaco-therapeutic bag 6, the upside of the corresponding cavity of described cover body
Face arranges removable cover 7, the one side setting pellosil 8 that described cover body is contacted with eye, and described pellosil corresponds to circumference of eyes acupuncture point
It is provided with prominent vesicle 9, setting massage bead 10 in each described prominent vesicle, described massage bead connecting vibration motor 11, described shakes
Galvanic electricity machine and power supply 12 connect, setting temperature sensor 13 and microcontroller 14 in described cover body, and described temperature sensor is led to
Cross wire 15 to be connected with microcontroller and power supply successively.
In the present invention, the material of cover body 1 selects the little pvc material of heat conductivity.
Magic glues fixing band 2, and length and elasticity are adjustable, are voluntarily adjusted according to the head size of different users,
Practical and convenient.The one end of the viscous fixing band of magic is located in the both sides of above-mentioned cover body, and the other end is provided with VELCRO.
In the present invention, massage bead 10 is fixed in connecting rod 16, and described connecting rod is connected with described vibrating motor 11.Specifically
, refering to Fig. 3, massage bead is fixed in connecting rod by haftplatte 19, and the side of the corresponding massage bead of haftplatte has groove 20, massage
Pearl is fastened in groove.Vibrating motor includes micromotor and eccentric, and massage bead is connected with vibrating motor by connecting rod,
In the presence of vibrating motor, realize massage effect.
Connecting rod 16 is fixed on the inside of described cover body by elastic component 17.Elastic component 17 thrum spring, elastic force bar or other
Has resilient connection member.
In the present invention, the upside of interlayer 4 is opening, does not fix with cover body, so interbedded fever tablet or
Pharmaco-therapeutic bag just can take out replacing at removable cover.Interlayer is preferably carbon fiber product, and mechanical properties of carbon fibre is good, and has
There is far-infrared effect.In the present invention, setting 2 layer interlayers, one layer of fixing fever tablet, another layer of fixing pharmaco-therapeutic bag in cavity 3.
Fever tablet 5 is spontaneous heating material or heating power material, provides physics thermotherapy for user, is also pharmaco-therapeutic bag simultaneously
Thermal source is provided, improves the effect of medication, for example: Electric radiant Heating Film, Far infrared carbon fiber fever tablet etc..When this fever tablet is heating power
During material, it is sequentially connected with microcontroller and power supply, in order to control the heating of fever tablet.
Fever tablet 5 is preferably Far infrared carbon fiber fever tablet, and it can play far infrared health care effect while providing heat
Really, one-object-many-purposes, effect is significant.
Pharmaco-therapeutic bag 6 is that will have alleviation eye strain or improve the placement of the medicines such as ocular circulation in this layer, pass through
Thermotherapy, activates eye meridians, strengthens the transdermal administration of medicine, improves the curative effect of medicine.
In the present invention, the shape of prominent vesicle 9 is closed with massage bead matching form, and spherical, ellipsoid etc. can be selected round and smooth
Shape.
Embodiment 2
Refering to Fig. 3, the asthenopic eyeshield of the alleviation described by the present embodiment, wherein:
Cover body 1 is double-decker, is air or evacuation, reduces radiating, improve heat-insulating property between bilayer.
Embodiment 3
Refering to Fig. 3, the asthenopic eyeshield of the alleviation described by the present embodiment, wherein:
The inner surface of described cover body lays aluminium foil reflectance coating 18.
Aluminium foil reflectance coating 18 energy reflected radiation heat, thus realizing heat-insulated and insulation effect, used for this invention, can will send out
The heat of thermosphere release is reflected back the direction of human body eye, makes drug absorption arrive more heats;Simultaneously moreover it is possible to reduce in cover body
The heat in portion space scatters and disappears.
Embodiment 4
The asthenopic eyeshield of alleviation described by the present embodiment, based on embodiment 1, wherein:
Setting Folium Artemisiae Argyi in described pharmaco-therapeutic bag 6.
Effect of Chinese mugwort, records according to " Guangxi Chinese medicinal herbal ": " open hole powder fire, nebula of dispelling improving eyesight.Control abdominal pain due to acute vomiting and diarrhea, wind-phlegm closes key.Outward
For mesh disease external oculopathy, aphtha etc. is demonstrate,proved, and can make to prepare the application compress of traumatic injury." the present embodiment is disposed in pharmaco-therapeutic bag,
It is conveniently replaceable, is not contaminated, add the heat supply of fever tablet, the performance that can strengthen Chinese mugwort drug effect is so that Ai Ming purpose effect
More notable.
Embodiment 5
Refering to Fig. 1, the asthenopic eyeshield of the alleviation described by the present embodiment, based on embodiment 4, wherein:
Described magic is glued and is closed acupuncture point on the corresponding human body of fixing band 2 and put sandwich establishment 21, described interlayer 21 setting heat sensitizer and
Blumeae preparatum Tabellae.
Described heat sensitizer may be selected the cephrol butyl ether that market is sold, and has thermal sensation effect to skin;Blumeae preparatum Tabellae is Ai Chengpin.
Additionally it is possible to close cave on stimulating so while alleviating eye strain, thus alleviating headache, tinnitus, deaf, ear, mouth eye is askew
Tiltedly, prosopodynia, toothache, infantile convulsion, the symptom such as clonic convulsion, the treatment beneficial to ocular disease and elimination.
Embodiment 6
The asthenopic eyeshield of alleviation described by the present embodiment, based on embodiment 1, wherein:
Described pharmaco-therapeutic bag 6 is the bag of installing treatment solution, and described treatment solution is prepared from by the raw material of following weight portion: salt alkali 8
Part, 15 parts of Herba Menthae, 15 parts of Fructus Aurantii Immaturus, 8 parts of Radix Bupleuri, 7 parts of Rhizoma Dioscoreae, 5 parts of Folium et cacumen Breyniae Fruticosae, 6 parts of Fructus Bruceae, 3 parts of Melanteritum.
Treatment solution described in the present embodiment is prepared by method and obtains, and specifically includes:
1) weigh Herba Menthae, Fructus Aurantii Immaturus, Radix Bupleuri, Rhizoma Dioscoreae, Folium et cacumen Breyniae Fruticosae and the Fructus Bruceae of above-mentioned weight portion, be added to supercritical co2Extraction
In kettle, extracted for entrainer using volume fraction 95% ethanol, set extracting pressure 15mpa, 35 DEG C of temperature, co2Fluid stream
Amount 42l/h, extracts 2h, and gained extract frozen centrifugation removes impurity, obtains pure extract;
2) weigh salt alkali and the Melanteritum of above-mentioned weight portion, be ground to powder, add to described pure extract, stirring mixing,
Standing obtains final product.
Present invention applicant passes through to explore and test practice, finds salt alkali, Herba Menthae, Fructus Aurantii Immaturus, Radix Bupleuri, Rhizoma Dioscoreae, Folium et cacumen Breyniae Fruticosae, crow
Courage and Melanteritum have significant curative effect by cooperation to pre- myopia prevention, add thermotherapy and magnetic therapy, being capable of rapid recovery and recovery trouble
The ill symptomses such as the mesh of person is puckery, blurred vision, promote the Transdermal absorption of medicine, and then realize the effect for the treatment of both the principal and secondary aspects of a disease.Wherein, salt alkali,
The crystallization of the materials such as the magnesium chloride condensing for salt brine.Dry, pulverize use.Herba Menthae, is Labiatae mint Herba Menthae
Dry aerial parts, pungent, cool, return lung, Liver Channel, dispelling wind-heat, refresh oneself, rash.Fructus Aurantii Immaturus, is the dry of rutaceae Citrus aurantium Linn.
Dry young fruit.Bitter, pungent, sour, temperature.Dispelling the stagnated QI removing food stagnancy, resolving sputum dissipates painful abdominal mass.Radix Bupleuri, is the dry root of umbelliferae bupleurum, bitter, is slightly cold.With
Solution the exterior and the interior, soothing the liver, yang invigorating.Rhizoma Dioscoreae, is the dry rhizome of Dioscoreaceae plant Rhizoma Dioscoreae, sweet, puts down.Spleen reinforcing nourishing the stomach, engender liquid and benefic lung, the kidney invigorating
Arresting seminal emission.Folium et cacumen Breyniae Fruticosae, stem platymiscium black flour tree is painted on Euphorbiaceae mountain, is used as medicine with leaf.Slight bitter, cool.Slightly poisonous.Heat-clearing and toxic substances removing, dissipating blood stasis, only
Bitterly, antipruritic.Fructus Bruceae, is the dry mature fruit of quassia Fructus Bruceae.Hardship, trembles with fear;Slightly poisonous.Heat clearing away, dampness, parasite killing,
Removing toxic substances.Melanteritum, is the Ore of Sulfateses mineral inkstone.Sour and astringent, cool.Drying dampness to eliminate phlegm, eliminating stagnated food and killing intestinal worms, hemostasis is enriched blood, removing toxic substances
Sore.
Embodiment 7
The asthenopic eyeshield of alleviation described by the present embodiment, based on embodiment 1, wherein:
Described pharmaco-therapeutic bag 6 is the bag of installing treatment solution, and described treatment solution is prepared from by the raw material of following weight portion: salt alkali 5
Part, 10 parts of Herba Menthae, 10 parts of Fructus Aurantii Immaturus, 5 parts of Radix Bupleuri, 5 parts of Rhizoma Dioscoreae, 3 parts of Folium et cacumen Breyniae Fruticosae, 3 parts of Fructus Bruceae, 1 part of Melanteritum.
Treatment solution described in the present embodiment is prepared by method and obtains, and specifically includes:
1) weigh Herba Menthae, Fructus Aurantii Immaturus, Radix Bupleuri, Rhizoma Dioscoreae, Folium et cacumen Breyniae Fruticosae and the Fructus Bruceae of above-mentioned weight portion, be added to supercritical co2Extraction
In kettle, extracted for entrainer using volume fraction 95% ethanol, set extracting pressure 10mpa, 30 DEG C of temperature, co2Fluid stream
Amount 40l/h, extracts 1.5h, and gained extract frozen centrifugation removes impurity, obtains pure extract;
2) weigh salt alkali and the Melanteritum of above-mentioned weight portion, be ground to powder, add to described pure extract, stirring mixing,
Standing obtains final product.
Embodiment 8
The asthenopic eyeshield of alleviation described by the present embodiment, based on embodiment 1, wherein:
Described pharmaco-therapeutic bag 6 is the bag of installing treatment solution, and described treatment solution is prepared from by the raw material of following weight portion: salt alkali 10
Part, 20 parts of Herba Menthae, 20 parts of Fructus Aurantii Immaturus, 10 parts of Radix Bupleuri, 10 parts of Rhizoma Dioscoreae, 8 parts of Folium et cacumen Breyniae Fruticosae, 8 parts of Fructus Bruceae, 5 parts of Melanteritum.
Treatment solution described in the present embodiment is prepared by method and obtains, and specifically includes:
1) weigh Herba Menthae, Fructus Aurantii Immaturus, Radix Bupleuri, Rhizoma Dioscoreae, Folium et cacumen Breyniae Fruticosae and the Fructus Bruceae of above-mentioned weight portion, be added to supercritical co2Extraction
In kettle, extracted for entrainer using volume fraction 95% ethanol, set extracting pressure 20mpa, 40 DEG C of temperature, co2Fluid stream
Amount 50l/h, extracts 3h, and gained extract frozen centrifugation removes impurity, obtains pure extract;
2) weigh salt alkali and the Melanteritum of above-mentioned weight portion, be ground to powder, add to described pure extract, stirring mixing,
Standing obtains final product.
Comparative example 1
The asthenopic eyeshield of alleviation described by this comparative example, as different from Example 6: omit setting fever tablet 5, only in sky
Setting pharmaco-therapeutic bag 6 in the interlayer in chamber, pharmaco-therapeutic bag 6 refers to embodiment 6.
Comparative example 2
The asthenopic eyeshield of alleviation described by this comparative example, as different from Example 6: described treatment solution is prepared by
Method obtains, and specifically includes:
Weigh Herba Menthae, Fructus Aurantii Immaturus, Radix Bupleuri, Rhizoma Dioscoreae, Folium et cacumen Breyniae Fruticosae and the Fructus Bruceae of above-mentioned weight portion, put in frying pan, addition weight is
The water that 10 times of above-mentioned raw materials weight, 70 DEG C of design temperature is decocted, and decocting time is 40 minutes;After decoction finishes, mistake while hot
Filter, obtains filtrate;Weigh salt alkali and the Melanteritum of above-mentioned weight portion, be ground to powder, add in filtrate and be sufficiently stirred for, fill after cooling
Enter bag, as medication layer.
Test effect
Asthenopic eyeshield is alleviated to the present invention and carries out following experimental study and statistics, be described in detail below:
1) EXPERIMENTAL DESIGN:
Test group a1 ~ a4: be respectively the eyeshield described by embodiment 4 ~ 7;
Eyeshield described by matched group b1, b2: comparative example 1 ~ 2;
Blank group: using commercial good vision eye sticker.
Observe case totally 140, be randomly divided into 7 groups, every group 20, there was no significant difference for every group of physical data.
Inclusive criteria: 1) have the one of which such as myopia, hypermetropia, anisometropia, astigmatism or multinomial ametropia state;Symbol
Close asthenopia diagnosis, being unable to see for a long time, have temporary blurred vision;2) eye have dry and astringent, burning sensation, itch, distending pain, the disease such as shed tears
Shape;3) headache and dizzy, hypomnesis, insomnia.3 ~ 5 possessed in 1,2 symptoms i.e. diagnosable.
2) test method: early, middle and late daily each 1 time, every time using 20 ~ 25 minutes, 5 days be 1 course for the treatment of;Treated using 4
Journey.
3) evaluation criterion: cure, eye symptom disappears, duration of photopic vision percentage ratio >=90%;Effective, eye symptom is obvious
Improve, 60%≤duration of photopic vision percentage ratio < 90%;Effectively, eye symptom is most of improves, 30% < duration of photopic vision percentage ratio
< 60%;Invalid, eye symptom no improves or deteriorates, duration of photopic vision percentage ratio≤30%.
Visuognosis persistence test is for evaluating a kind of asthenopic common method, wherein,
Duration of photopic vision percentage ratio/%=(photopic vision time/watch total time attentively) × 100%.
4) therapeutic outcome, is shown in Table 1.
Duration of photopic vision percentage ratio (%) and comparitive study [example (%)] between 7 groups after table 1 treatment
Project | Duration of photopic vision percentage ratio (± s)/% | Total case number of cases | Cure | Effective | Effectively | Do not heal | Always effective |
a1 | 70.41±10.03 | 20 | 5/25 | 8/40 | 6/30 | 1/5 | 20/95 |
a2 | 76.35±9.21 | 20 | 7/35 | 9/45 | 4/20 | 0 | 20/100 |
a3 | 87.12±8.52 | 20 | 11/55 | 8/40 | 1/5 | 0 | 20/100 |
a4 | 85.03±6.35 | 20 | 10/50 | 8/40 | 2/10 | 0 | 20/100 |
b1 | 59.23±9.14 | 20 | 2/10 | 5/25 | 11/55 | 2/10 | 20/90 |
b2 | 72.45±8.63 | 20 | 5/25 | 9/45 | 5/25 | 1/5 | 20/95 |
Blank group | 50.16±8.67 | 20 | 1/5 | 2/10 | 12/60 | 5/25 | 20/75 |
Note: total effective rate=cure rate+obvious effective rate+effective percentage.
From table 1, for duration of photopic vision percentage ratio, test group a3 highest, a4 is lower slightly compared with a3;And a1 is compared with a3 difference
Significantly, a2 is higher than then a1;B1 shows eyeshield of the present invention to regarding tired compared with test group significant difference, b2 compared with a3 and a4 significant difference
The improvement of labor is the most obvious.
After treatment, curative effect compares two-by-two, and b1 has statistical significance compared with a1, a2, a3 or a4, and b2 has statistics compared with a3 or a4
Learn meaning.Result shows, test group a3 and a4 are better than test group a1 and a2, are significantly better than matched group b1 and b2 again.
To sum up, test group of the present invention is to asthenopic remission effect substantially, evident in efficacy, can complete incidence graph teen-age
Asthenopia symptom.
Finally illustrate, only in order to technical scheme to be described and unrestricted, this area is common for above example
Other modifications or equivalent that technical staff is made to technical scheme, without departing from technical solution of the present invention
Spirit and scope, all should cover in the middle of scope of the presently claimed invention.
Claims (10)
1. a kind of alleviate asthenopic eyeshield it is characterised in that: include cover body, the two ends setting magic cementation of described cover body is fixed
Band, the corresponding human body eye locations of described cover body outwardly form cavity, arrange some interlayers, described interlayer in described cavity
Interior sensing human body eye direction sets gradually fever tablet and pharmaco-therapeutic bag, the upper side setting removable cover of the corresponding cavity of described cover body,
The one side setting pellosil that described cover body is contacted with eye, the corresponding circumference of eyes acupuncture point of described pellosil is provided with prominent vesicle, often
Setting massage bead in individual described prominent vesicle, described massage bead connecting vibration motor, described vibrating motor and power supply connect, described
Setting temperature sensor and microcontroller in cover body, described temperature sensor pass through wire successively with microcontroller and power supply
Connect.
2. as claimed in claim 1 alleviation asthenopic eyeshield it is characterised in that: described massage bead is fixed in connecting rod,
Described connecting rod is connected with described vibrating motor.
3. as claimed in claim 2 alleviation asthenopic eyeshield it is characterised in that: described connecting rod is fixed on by elastic component
The inside of described cover body.
4. as claimed in claim 1 alleviation asthenopic eyeshield it is characterised in that: described cover body inner surface lay aluminium foil reflection
Film.
5. as claimed in claim 1 alleviation asthenopic eyeshield it is characterised in that: described interlayer be carbon fiber interlayer.
6. as claimed in claim 1 alleviation asthenopic eyeshield it is characterised in that: described fever tablet be Electric radiant Heating Film or far infrared
Carbon fiber heating piece, described fever tablet is connected with power supply.
7. the asthenopic eyeshield of alleviation as claimed in claim 1 it is characterised in that: setting Folium Artemisiae Argyi in described pharmaco-therapeutic bag.
8. as claimed in claim 1 alleviate asthenopic eyeshield it is characterised in that: described pharmaco-therapeutic bag be installing treatment solution bag
Body, described treatment solution is prepared from by the raw material of following weight portion: 5 ~ 10 parts of salt alkali, 10 ~ 20 parts of Herba Menthae, 10 ~ 20 parts of Fructus Aurantii Immaturus, bavin
5 ~ 10 parts recklessly, 5 ~ 10 parts of Rhizoma Dioscoreae, 3 ~ 8 parts of Folium et cacumen Breyniae Fruticosae, 3 ~ 8 parts of Fructus Bruceae, 1 ~ 5 part of Melanteritum.
9. as claimed in claim 8 alleviate asthenopic eyeshield it is characterised in that: described pharmaco-therapeutic bag be installing treatment solution bag
Body, described treatment solution is prepared from by the raw material of following weight portion: 8 parts of salt alkali, 15 parts of Herba Menthae, 15 parts of Fructus Aurantii Immaturus, 8 parts of Radix Bupleuri, mountain
7 parts of medicine, 5 parts of Folium et cacumen Breyniae Fruticosae, 6 parts of Fructus Bruceae, 3 parts of Melanteritum.
10. as claimed in claim 9 alleviation asthenopic eyeshield it is characterised in that: the described treatment solution side of being prepared by
Method obtains, and specifically includes:
1) weigh Herba Menthae, Fructus Aurantii Immaturus, Radix Bupleuri, Rhizoma Dioscoreae, Folium et cacumen Breyniae Fruticosae and the Fructus Bruceae of above-mentioned weight portion, be added to supercritical co2 extraction
In kettle, extracted for entrainer using volume fraction 95% ethanol, set extracting pressure 10 ~ 20mpa, 30 ~ 40 DEG C of temperature, co2
Fluid flow 40 ~ 50l/h, extracts 1.5 ~ 3h, and gained extract frozen centrifugation removes impurity, obtains pure extract;
2) weigh salt alkali and the Melanteritum of above-mentioned weight portion, be ground to powder, add to described pure extract, stirring mixing,
Standing obtains final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611054594.XA CN106344262A (en) | 2016-11-25 | 2016-11-25 | Eye patch for relieving visual fatigue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611054594.XA CN106344262A (en) | 2016-11-25 | 2016-11-25 | Eye patch for relieving visual fatigue |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106344262A true CN106344262A (en) | 2017-01-25 |
Family
ID=57862953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611054594.XA Pending CN106344262A (en) | 2016-11-25 | 2016-11-25 | Eye patch for relieving visual fatigue |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106344262A (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106901896A (en) * | 2017-02-21 | 2017-06-30 | 云南彝药生物科技有限公司 | A kind of detoxifying health-care eyeshade |
CN107157756A (en) * | 2017-06-29 | 2017-09-15 | 李紫丰 | Alleviate the pressing device of visual fatigue |
CN107184310A (en) * | 2017-05-27 | 2017-09-22 | 南京晶云化工有限公司 | A kind of eyeshade for being used to treat visual fatigue |
CN107242934A (en) * | 2017-07-26 | 2017-10-13 | 山东仲景健康服务有限公司 | A kind of Traditional Chinese medicine eyeshade for repairing mobile phone eye |
CN107296685A (en) * | 2017-06-26 | 2017-10-27 | 韩明磊 | A kind of massage eye-shield with protect eyes function |
CN108175950A (en) * | 2018-01-22 | 2018-06-19 | 陈宇甦 | A kind of fever eye treatment device |
CN108836627A (en) * | 2018-03-23 | 2018-11-20 | 南京唐微数字科技有限公司 | A kind of multi-functional blindfolds |
CN108888501A (en) * | 2018-05-22 | 2018-11-27 | 郭洪云 | A kind of alkene heat Chinese mugwort steams eye physical therapy equipment and its application method |
CN108938359A (en) * | 2018-04-13 | 2018-12-07 | 广州市康亦健医疗设备有限公司 | A kind of ocular region massaging device |
CN109044618A (en) * | 2018-08-17 | 2018-12-21 | 广州普敬智能装备科技有限公司 | A kind of intelligence eyeshade |
CN110353880A (en) * | 2019-06-28 | 2019-10-22 | 四川省一直牛健康管理有限公司 | A far infrared and the fever eyeshade of fragrant plant compatibility and preparation method thereof |
CN110393623A (en) * | 2019-07-25 | 2019-11-01 | 北京爽视医疗器械有限公司 | Eye ice Shu Yi device |
CN111904714A (en) * | 2020-09-04 | 2020-11-10 | 吴宝成 | Formula and using method of steam eyeshade medicine bag |
CN112107410A (en) * | 2020-09-22 | 2020-12-22 | 苏州工艺美术职业技术学院 | Eyeshade with monitoring function for treating asthenopia |
CN114376876A (en) * | 2022-01-17 | 2022-04-22 | 湖南中医药大学 | Lens trainer for ophthalmology rehabilitation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011049419A2 (en) * | 2009-10-23 | 2011-04-28 | (주)스페이스파워 | Face support having a drug carrier |
CN104873329A (en) * | 2015-06-25 | 2015-09-02 | 胡秀萍 | Health-care massage blinder |
CN204744881U (en) * | 2015-05-26 | 2015-11-11 | 天津市华康利安科技发展有限公司 | Eye massage appearance |
CN204798346U (en) * | 2015-05-12 | 2015-11-25 | 李艳瑶 | Stifling eye physiotherapy device of wearing type far infrared ultrasonic wave constant temperature medicine fog |
CN205234766U (en) * | 2015-12-17 | 2016-05-18 | 天津天源康生物科技有限公司 | Health care eye patch |
-
2016
- 2016-11-25 CN CN201611054594.XA patent/CN106344262A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011049419A2 (en) * | 2009-10-23 | 2011-04-28 | (주)스페이스파워 | Face support having a drug carrier |
CN204798346U (en) * | 2015-05-12 | 2015-11-25 | 李艳瑶 | Stifling eye physiotherapy device of wearing type far infrared ultrasonic wave constant temperature medicine fog |
CN204744881U (en) * | 2015-05-26 | 2015-11-11 | 天津市华康利安科技发展有限公司 | Eye massage appearance |
CN104873329A (en) * | 2015-06-25 | 2015-09-02 | 胡秀萍 | Health-care massage blinder |
CN205234766U (en) * | 2015-12-17 | 2016-05-18 | 天津天源康生物科技有限公司 | Health care eye patch |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106901896A (en) * | 2017-02-21 | 2017-06-30 | 云南彝药生物科技有限公司 | A kind of detoxifying health-care eyeshade |
CN107184310A (en) * | 2017-05-27 | 2017-09-22 | 南京晶云化工有限公司 | A kind of eyeshade for being used to treat visual fatigue |
CN107296685A (en) * | 2017-06-26 | 2017-10-27 | 韩明磊 | A kind of massage eye-shield with protect eyes function |
CN107157756A (en) * | 2017-06-29 | 2017-09-15 | 李紫丰 | Alleviate the pressing device of visual fatigue |
CN107242934A (en) * | 2017-07-26 | 2017-10-13 | 山东仲景健康服务有限公司 | A kind of Traditional Chinese medicine eyeshade for repairing mobile phone eye |
CN108175950A (en) * | 2018-01-22 | 2018-06-19 | 陈宇甦 | A kind of fever eye treatment device |
CN108836627A (en) * | 2018-03-23 | 2018-11-20 | 南京唐微数字科技有限公司 | A kind of multi-functional blindfolds |
CN108938359A (en) * | 2018-04-13 | 2018-12-07 | 广州市康亦健医疗设备有限公司 | A kind of ocular region massaging device |
CN108888501A (en) * | 2018-05-22 | 2018-11-27 | 郭洪云 | A kind of alkene heat Chinese mugwort steams eye physical therapy equipment and its application method |
CN109044618A (en) * | 2018-08-17 | 2018-12-21 | 广州普敬智能装备科技有限公司 | A kind of intelligence eyeshade |
CN110353880A (en) * | 2019-06-28 | 2019-10-22 | 四川省一直牛健康管理有限公司 | A far infrared and the fever eyeshade of fragrant plant compatibility and preparation method thereof |
CN110393623A (en) * | 2019-07-25 | 2019-11-01 | 北京爽视医疗器械有限公司 | Eye ice Shu Yi device |
CN111904714A (en) * | 2020-09-04 | 2020-11-10 | 吴宝成 | Formula and using method of steam eyeshade medicine bag |
CN112107410A (en) * | 2020-09-22 | 2020-12-22 | 苏州工艺美术职业技术学院 | Eyeshade with monitoring function for treating asthenopia |
CN114376876A (en) * | 2022-01-17 | 2022-04-22 | 湖南中医药大学 | Lens trainer for ophthalmology rehabilitation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106344262A (en) | Eye patch for relieving visual fatigue | |
CN102139038A (en) | Chinese herbal preparation for treating eye diseases | |
CN109620909A (en) | Chinese medicine composition, Chinese medicine eye mask and its preparation and application | |
CN106880782A (en) | Disease-relieving and physique enhancing medicine-filled pillow | |
CN100459958C (en) | Chinese medicine heat therapy eyeshade and its medicine | |
CN104887474A (en) | Convenient type merdian-collateral physical therapy instrument | |
CN102864063A (en) | Pepper health protection wine and preparation method thereof | |
CN106388996A (en) | Eye nursing device for preventing shortsightedness | |
CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
CN106139028A (en) | A kind of Traditional Chinese medicinal liquor treating cervical spondylosis | |
Goyal et al. | Ayurveda the ancient science of healing: an insight | |
CN102283539B (en) | Medicinal pillow for preventing and treating cervical spondylosis | |
CN104524058A (en) | Traditional Chinese medicine preparation for treating cerebral concussion and preparation method | |
CN104971204B (en) | A kind of kidney tonifying for coordinating acupuncture and moxibustion therapy nervous tinnitus is had one's ideas straightened out ball and medicinal strip | |
CN103405637B (en) | Drug for treating neurosis and preparation method thereof | |
CN103638510B (en) | A kind of Chinese medicinal formulae for the treatment of neck-shoulder pain, lumbago and leg pain and preparation method thereof | |
CN103371908A (en) | Implementation procedure for fire therapy | |
CN101417054B (en) | Traditional Chinese medicine composite for treating dizziness | |
CN103202641B (en) | A kind of cervical vertebrae correction therapeutic medicine-filled pillow | |
CN105878627A (en) | Traditional Chinese medicine formula for treating myopic disease | |
CN110664609A (en) | Eye disease fumigation therapeutic instrument | |
CN103520412A (en) | Chinese medicinal decoction for treating meniere vertigo | |
CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
CN105796749A (en) | Acupoint massage and traditional Chinese medicine composition for relieving asthenopia | |
CN101984882B (en) | Health-care medicinal pillow for preventing cervical spondylosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170125 |